HOME › DRUGS › RUBITECAN
ACTIVE SUBSTANCE / INN

RUBITECAN

Brand name(s): Orathecin
EMA LISTED
APPLICATION WITHDRAWN
Pancreatic Neoplasms
ACTIVE SUBSTANCE
Rubitecan
REGULATORS
EMA
SPONSORS / MAH
EuroGen Pharmaceuticals Ltd
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
OrathecinEuroGen Pharmaceuticals LtdApplication withdrawnPancreatic Neoplasms

FULL INTELLIGENCE ON RUBITECAN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →